"""
Supplement Interaction Checker — evidence-based interaction database + Claude analysis.

Covers:
- Supplement–supplement interactions
- Supplement–drug interactions
- Nutrient depletion patterns
- Synergistic combinations

Data hierarchy:
  Level A: High-quality RCTs / systematic reviews (labeled 🟢)
  Level B: Clinical case series / pharmacokinetic data (labeled 🟡)
  Level C: Mechanistic / theoretical / in vitro (labeled 🟠)
  Level D: Anecdotal / preliminary (labeled 🔵)

If an interaction isn't in the local database, the analyzer falls back to
Claude Opus 4.6 with adaptive thinking for evidence synthesis.
"""
from __future__ import annotations

import re
from dataclasses import dataclass, field
from typing import Literal

import anthropic

# ── Interaction severity ───────────────────────────────────────────────────────

Severity = Literal["synergistic", "safe", "monitor", "caution", "avoid"]

SEVERITY_EMOJI = {
    "synergistic": "🤝",
    "safe": "✅",
    "monitor": "👁️",
    "caution": "⚠️",
    "avoid": "🚫",
}

SEVERITY_ORDER = {"avoid": 0, "caution": 1, "monitor": 2, "safe": 3, "synergistic": 4}


# Anything outside [a-z0-9] gets squashed to underscores so the resulting key
# is safe as both a JSON object key and a next-intl namespace path component.
_KEY_NORM_RE = re.compile(r"[^a-z0-9]+")


def _make_key(compound_a: str, compound_b: str, field: str) -> str:
    """Generate the canonical i18n lookup key for one (pair, field) tuple.

    Used by next-intl on the Calsanova frontend (and downstream consumers
    Kiwi / RWQL if they wire localization later) to look up the localized
    `mechanism` or `recommendation` string for a given Interaction row.

    Algorithm — deterministic + idempotent + alphabetization-stable:
      1. lowercase both compound strings, strip whitespace
      2. replace any char outside [a-z0-9] with `_`
      3. collapse runs of `_` to a single `_`, strip leading/trailing `_`
      4. sort the two normalized strings alphabetically (so the key for
         (caffeine, melatonin) equals the key for (melatonin, caffeine))
      5. join the two with `__`, append `__{field}`

    Examples:
      _make_key("Caffeine", "L-Theanine", "mechanism")
        → "caffeine__l_theanine__mechanism"
      _make_key("vitamin c", "iron", "recommendation")
        → "iron__vitamin_c__recommendation"
    """
    def _norm(s: str) -> str:
        s = _KEY_NORM_RE.sub("_", s.lower().strip())
        return s.strip("_")
    a, b = sorted([_norm(compound_a), _norm(compound_b)])
    return f"{a}__{b}__{field}"


@dataclass
class Interaction:
    compound_a: str
    compound_b: str
    severity: Severity
    mechanism: str
    evidence_tier: str   # 🟢 / 🟡 / 🟠 / 🔵
    recommendation: str
    sources: list[str] = field(default_factory=list)
    # i18n lookup keys — auto-generated in __post_init__ when left empty.
    # Frontends (e.g. Calsanova's next-intl) use these to render the
    # localized mechanism/recommendation strings; English values above
    # remain the canonical source + dev fallback.
    mechanism_key: str = ""
    recommendation_key: str = ""

    def __post_init__(self) -> None:
        if not self.mechanism_key:
            self.mechanism_key = _make_key(self.compound_a, self.compound_b, "mechanism")
        if not self.recommendation_key:
            self.recommendation_key = _make_key(self.compound_a, self.compound_b, "recommendation")

    def display(self) -> str:
        emoji = SEVERITY_EMOJI[self.severity]
        return (
            f"{emoji} {self.compound_a.title()} + {self.compound_b.title()}\n"
            f"   Severity: {self.severity.upper()} {self.evidence_tier}\n"
            f"   Mechanism: {self.mechanism}\n"
            f"   Recommendation: {self.recommendation}\n"
            + (f"   Sources: {', '.join(self.sources)}\n" if self.sources else "")
        )


# ── Evidence-based interaction database ───────────────────────────────────────

INTERACTION_DB: list[Interaction] = [
    # ── Synergistic combinations ──────────────────────────────────────────────
    Interaction(
        compound_a="creatine", compound_b="beta-alanine",
        severity="synergistic",
        mechanism="Creatine replenishes PCr for explosive power; beta-alanine buffers H+ during high-intensity glycolysis. Complementary energy system support.",
        evidence_tier="🟡",
        recommendation="Safe to combine. Creatine 3–5g/day + beta-alanine 3.2–6.4g/day. Stack timing not critical.",
        sources=["Zoeller et al. 2007 IJSN", "ISSN 2010 Position Stand"],
    ),
    Interaction(
        compound_a="caffeine", compound_b="l-theanine",
        severity="synergistic",
        mechanism="L-theanine attenuates caffeine-induced jitteriness and anxiety via GABA modulation while preserving cognitive enhancement effects.",
        evidence_tier="🟢",
        recommendation="Optimal ratio 2:1 (theanine:caffeine). 200mg L-theanine + 100mg caffeine. Enhances focus without overstimulation.",
        sources=["Haskell et al. 2008 Biol Psych", "Dodd et al. 2015 Nutr Rev"],
    ),
    Interaction(
        compound_a="vitamin d3", compound_b="vitamin k2",
        severity="synergistic",
        mechanism="Vitamin D3 upregulates calcium-binding proteins; K2 (MK-7) activates matrix GLA protein to direct calcium to bone rather than arteries.",
        evidence_tier="🟡",
        recommendation="Combine for bone density. D3 2000–4000 IU + K2 (MK-7) 100–200mcg daily. Critical for athletes with high bone stress.",
        sources=["Maresz 2015 Integ Med", "Kidd 2010 Alt Med Rev"],
    ),
    Interaction(
        compound_a="zinc", compound_b="magnesium",
        severity="synergistic",
        mechanism="ZMA (zinc + magnesium + B6) combination supports testosterone production, sleep quality, and recovery. Both are commonly depleted in athletes.",
        evidence_tier="🟡",
        recommendation="ZMA protocol: 30mg zinc + 450mg magnesium + 10.5mg B6 before bed on empty stomach.",
        sources=["Brilla & Conte 2000 J Ex Phys", "Kilic et al. 2010 Neuro Endocrinol"],
    ),
    Interaction(
        compound_a="vitamin c", compound_b="iron",
        severity="synergistic",
        mechanism="Vitamin C (ascorbic acid) reduces Fe³⁺ to Fe²⁺, dramatically enhancing non-heme iron absorption (up to 3-fold increase).",
        evidence_tier="🟢",
        recommendation="Take 250–500mg vitamin C with iron-rich meals or iron supplements. Critical for plant-based athletes.",
        sources=["Hallberg et al. 1989 Am J Clin Nutr", "Lynch 2011 Int J Vitam Nutr Res"],
    ),
    Interaction(
        compound_a="protein", compound_b="creatine",
        severity="synergistic",
        mechanism="No direct pharmacological synergy, but combined intake post-exercise maximizes mTOR activation (leucine) and PCr resynthesis.",
        evidence_tier="🟢",
        recommendation="Post-workout: 20–40g protein + 3–5g creatine. Timing within 30-min post-exercise optimal.",
        sources=["Cribb & Hayes 2006 Med Sci Sports", "ISSN 2017 Creatine Stand"],
    ),

    # ── Monitor combinations ──────────────────────────────────────────────────
    Interaction(
        compound_a="caffeine", compound_b="creatine",
        severity="monitor",
        mechanism="Early studies suggested caffeine impaired creatine phosphorylation; more recent research shows no significant interaction at standard doses.",
        evidence_tier="🟡",
        recommendation="Current evidence: safe to combine. However, high caffeine (>600mg/day) may impair PCr recovery. Moderate caffeine fine.",
        sources=["Vandenberghe et al. 1996 J Appl Physiol", "Hespel et al. 2002 J Appl Physiol"],
    ),
    Interaction(
        compound_a="beta-alanine", compound_b="sodium bicarbonate",
        severity="synergistic",
        mechanism="Both buffer acidosis via different mechanisms: BA increases carnosine (intracellular); NaHCO3 buffers extracellular pH. Additive effect.",
        evidence_tier="🟡",
        recommendation="Combine for events 1–10 min. NaHCO3 0.3g/kg + BA 3.2g/day. NaHCO3 GI distress risk — test in training first.",
        sources=["Sale et al. 2011 Int J Sport Nutr", "Jones et al. 2016 EJAP"],
    ),
    Interaction(
        compound_a="st john's wort", compound_b="caffeine",
        severity="caution",
        mechanism="St John's Wort induces CYP1A2, the primary caffeine-metabolizing enzyme, potentially altering caffeine clearance rates.",
        evidence_tier="🟠",
        recommendation="If taking St John's Wort, caffeine sensitivity may change. Start with lower doses and monitor response.",
        sources=["Dresser et al. 2003 Clin Pharmacol Ther"],
    ),

    # ── Caution combinations ──────────────────────────────────────────────────
    Interaction(
        compound_a="iron", compound_b="calcium",
        severity="caution",
        mechanism="Calcium competitively inhibits iron absorption via shared DMT1 transporter. Dairy-based calcium most problematic.",
        evidence_tier="🟢",
        recommendation="Separate iron supplements/high-iron meals from dairy/calcium supplements by 2+ hours.",
        sources=["Hallberg 1998 Scand J Nutr", "Lönnerdal 2010 J Nutr"],
    ),
    Interaction(
        compound_a="zinc", compound_b="iron",
        severity="caution",
        mechanism="High-dose zinc (>40mg/day) competes with iron for absorption via DMT1. Relevant for athletes supplementing both.",
        evidence_tier="🟢",
        recommendation="Take zinc and iron supplements at different times. Whole food sources show less competition than supplements.",
        sources=["Solomons 1986 J Nutr", "Whittaker 1998 Am J Clin Nutr"],
    ),
    Interaction(
        compound_a="vitamin e", compound_b="fish oil",
        severity="caution",
        mechanism="High-dose fish oil increases oxidative stress from PUFA peroxidation; vitamin E may partially mitigate but high doses of both unneeded.",
        evidence_tier="🟠",
        recommendation="If taking >3g/day EPA+DHA, include adequate dietary vitamin E. High supplemental doses of both not recommended.",
        sources=["Higdon & Frei 2001 Biofactors"],
    ),

    # ── Avoid combinations ────────────────────────────────────────────────────
    Interaction(
        compound_a="melatonin", compound_b="caffeine",
        severity="avoid",
        mechanism="Caffeine is an adenosine antagonist that directly blocks melatonin's sleep-promoting mechanisms. CYP1A2 also metabolizes both — competitive inhibition.",
        evidence_tier="🟢",
        recommendation="Do not consume caffeine <6 hours before melatonin administration. Caffeine half-life 5–6 hours; consider genetic variation (CYP1A2 fast/slow metabolizers).",
        sources=["Viola et al. 2007 Physiol Behav", "Drake et al. 2013 J Clin Sleep Med"],
    ),
    Interaction(
        compound_a="warfarin", compound_b="vitamin k",
        severity="avoid",
        mechanism="Warfarin's anticoagulant mechanism antagonizes vitamin K. Even moderate vitamin K intake changes INR significantly.",
        evidence_tier="🟢",
        recommendation="CRITICAL: Athletes on anticoagulation therapy must not alter vitamin K intake without physician guidance. Consistent (not zero) intake is the goal.",
        sources=["Schurgers et al. 2004 Thromb Haemost", "FDA Warfarin prescribing info"],
    ),
    Interaction(
        compound_a="5-htp", compound_b="ssri",
        severity="avoid",
        mechanism="5-HTP increases serotonin precursor availability; SSRIs block serotonin reuptake. Combined risk of serotonin syndrome.",
        evidence_tier="🟡",
        recommendation="CONTRAINDICATED: Do not combine 5-HTP with any serotonergic medication without medical supervision.",
        sources=["Turner et al. 2006 Psychopharmacology"],
    ),

    # ── New interactions for expanded supplement DB ──────────────────────────

    Interaction(
        compound_a="citrulline", compound_b="nitrate",
        severity="synergistic",
        mechanism="Citrulline provides arginine substrate for eNOS; nitrates provide NO via nitrate→nitrite→NO pathway. Dual NO pathway activation.",
        evidence_tier="🟡",
        recommendation="Combine for enhanced nitric oxide production. 6g citrulline + 400mg nitrate (from beetroot). Take 60–90 min pre-exercise.",
        sources=["Bailey et al. 2015 Free Radic Biol Med"],
    ),
    Interaction(
        compound_a="citrulline", compound_b="pde5 inhibitors",
        severity="caution",
        mechanism="Both increase NO signaling — citrulline via arginine/eNOS, PDE5 inhibitors by preventing cGMP breakdown. Additive vasodilation and hypotension risk.",
        evidence_tier="🟡",
        recommendation="Use with caution. May cause excessive blood pressure drop. Consult physician before combining.",
        sources=["Schwedhelm et al. 2008 Br J Clin Pharmacol"],
    ),
    Interaction(
        compound_a="taurine", compound_b="beta-alanine",
        severity="monitor",
        mechanism="Share the same membrane transporter (TauT/SLC6A6). Chronic beta-alanine loading can reduce intracellular taurine by 15–20% via competitive inhibition.",
        evidence_tier="🟡",
        recommendation="If stacking long-term, supplement taurine 1–2g/d to offset depletion. Separate doses by 2+ hours.",
        sources=["Harris et al. 2006 Amino Acids", "Blancquaert et al. 2017 Med Sci Sports Exerc"],
    ),
    Interaction(
        compound_a="zinc", compound_b="copper",
        severity="caution",
        mechanism="Chronic zinc >40mg/d induces metallothionein in enterocytes which sequesters copper, causing secondary copper deficiency (sideroblastic anemia, neutropenia).",
        evidence_tier="🟢",
        recommendation="If supplementing zinc >30mg/d for >8 weeks, add 1–2mg copper daily. Monitor ceruloplasmin if symptomatic.",
        sources=["Prasad et al. 1978 JAMA", "IOM Dietary Reference Intakes for Zinc"],
    ),
    Interaction(
        compound_a="melatonin", compound_b="benzodiazepines",
        severity="caution",
        mechanism="Additive sedation via overlapping GABAergic and MT1/MT2 mechanisms. May cause excessive drowsiness, impaired coordination.",
        evidence_tier="🟡",
        recommendation="Do not combine without medical supervision. If used together, reduce melatonin to 0.3–0.5mg.",
        sources=["Garfinkel et al. 1999 Lancet"],
    ),
    Interaction(
        compound_a="tyrosine", compound_b="levodopa",
        severity="caution",
        mechanism="Compete for the same amino acid transporter (LAT1) across the blood-brain barrier. Tyrosine can reduce levodopa brain uptake.",
        evidence_tier="🟡",
        recommendation="Separate by 2+ hours. Patients on levodopa should not supplement tyrosine without neurologist guidance.",
        sources=["Growdon et al. 1982 Life Sci"],
    ),
    Interaction(
        compound_a="l-carnitine", compound_b="thyroid hormone",
        severity="caution",
        mechanism="L-carnitine inhibits thyroid hormone entry into the cell nucleus, potentially reducing T3/T4 action. Therapeutic in hyperthyroidism but problematic in hypothyroidism.",
        evidence_tier="🟡",
        recommendation="Hypothyroid patients on levothyroxine should monitor TSH if starting carnitine. May need dose adjustment.",
        sources=["Benvenga et al. 2004 Ann NY Acad Sci"],
    ),
    Interaction(
        compound_a="l-carnitine", compound_b="creatine",
        severity="synergistic",
        mechanism="Carnitine enhances fat oxidation (sparing glycogen); creatine enhances PCr resynthesis. Complementary energy system support at different intensities.",
        evidence_tier="🟠",
        recommendation="Safe to combine. Both require chronic loading. Take carnitine with carb meal, creatine any time.",
        sources=["Theoretical; no direct RCT on combination"],
    ),
    Interaction(
        compound_a="ashwagandha", compound_b="caffeine",
        severity="synergistic",
        mechanism="Ashwagandha reduces cortisol (via HPA axis modulation); caffeine acutely raises cortisol. Ashwagandha may buffer caffeine's cortisol spike while preserving alertness.",
        evidence_tier="🟠",
        recommendation="Safe to combine. Ashwagandha 300–600mg/d + caffeine as needed. May reduce jitteriness via GABAergic anxiolytic effect.",
        sources=["Chandrasekhar et al. 2012 Indian J Psychol Med", "Mechanistic rationale"],
    ),
    Interaction(
        compound_a="ashwagandha", compound_b="thyroid medication",
        severity="caution",
        mechanism="Ashwagandha may increase thyroid hormone levels (T3, T4) via stimulation of thyroid peroxidase activity. Can alter levothyroxine dosing requirements.",
        evidence_tier="🟡",
        recommendation="Monitor thyroid function if combining. May need levothyroxine dose adjustment. Contraindicated in hyperthyroidism.",
        sources=["Sharma et al. 2018 J Altern Complement Med"],
    ),
    Interaction(
        compound_a="omega-3", compound_b="anticoagulants",
        severity="caution",
        mechanism="Omega-3 fatty acids (EPA/DHA >3g/d) have mild antiplatelet and antithrombotic effects. Additive bleeding risk with warfarin, aspirin, or DOACs.",
        evidence_tier="🟡",
        recommendation="At standard doses (1–2g EPA+DHA) risk is low. Above 3g/d, monitor INR if on warfarin. Inform surgeon pre-operatively.",
        sources=["Gross et al. 2017 Thromb Res", "FDA safety communication 2014"],
    ),
    Interaction(
        compound_a="omega-3", compound_b="vitamin e",
        severity="synergistic",
        mechanism="Vitamin E protects polyunsaturated omega-3 fatty acids from lipid peroxidation. Many fish oil supplements include vitamin E as an antioxidant preservative.",
        evidence_tier="🟢",
        recommendation="Safe and beneficial to combine. 200–400 IU vitamin E with omega-3 supplements to prevent oxidation.",
        sources=["Ramos et al. 2008 Clin Nutr"],
    ),
    Interaction(
        compound_a="sodium bicarbonate", compound_b="caffeine",
        severity="synergistic",
        mechanism="Bicarb buffers H+ (peripheral), caffeine enhances CNS drive and adenosine blockade (central). Dual pathway performance enhancement.",
        evidence_tier="🟡",
        recommendation="Combine for high-intensity events (1–7 min). Take bicarb 0.3g/kg 60 min pre + caffeine 3mg/kg 30 min pre. GI distress risk increases with combination.",
        sources=["Higgins et al. 2016 JISSN", "Grgic & Mikulic 2021 J Sci Med Sport"],
    ),
    Interaction(
        compound_a="collagen", compound_b="vitamin c",
        severity="synergistic",
        mechanism="Vitamin C is a required cofactor for prolyl hydroxylase, the enzyme that cross-links collagen fibrils. Without vitamin C, collagen synthesis is impaired (scurvy mechanism).",
        evidence_tier="🟢",
        recommendation="ESSENTIAL combination: 15g collagen/gelatin + 50mg vitamin C, 30–60 min before exercise. Shaw et al. showed doubled collagen synthesis rate.",
        sources=["Shaw et al. 2017 Am J Clin Nutr", "DePhillipo et al. 2018 OJSM"],
    ),
    Interaction(
        compound_a="vitamin d", compound_b="magnesium",
        severity="synergistic",
        mechanism="Magnesium is required for vitamin D metabolism — it's a cofactor for 25-hydroxylase (liver) and 1α-hydroxylase (kidney) that convert D3 to active 1,25(OH)2D.",
        evidence_tier="🟡",
        recommendation="Co-supplement for optimal vitamin D activation. Mg deficiency can cause functional vitamin D deficiency even with adequate D3 intake.",
        sources=["Uwitonze & Razzaque 2018 J Am Osteopath Assoc", "Deng et al. 2013 BMC Med"],
    ),
    Interaction(
        compound_a="hmb", compound_b="creatine",
        severity="synergistic",
        mechanism="HMB reduces muscle protein breakdown (via ubiquitin-proteasome inhibition); creatine enhances MPS and PCr stores. Complementary anabolic/anti-catabolic pathways.",
        evidence_tier="🟡",
        recommendation="Safe to combine. 3g HMB-FA/d + 3–5g creatine/d. Most useful during caloric restriction or overreaching phases to preserve lean mass.",
        sources=["Jówko et al. 2001 Nutrition", "Wilson et al. 2013 JISSN"],
    ),
    Interaction(
        compound_a="glycerol", compound_b="creatine",
        severity="synergistic",
        mechanism="Both act as intracellular osmolytes. Creatine increases cell volume (ICF); glycerol expands total body water (ECF + ICF). Combined hyperhydration effect.",
        evidence_tier="🟠",
        recommendation="May enhance hyperhydration in heat. 1.2g/kg glycerol + standard creatine loading. Experimental — limited RCT data on combination.",
        sources=["Easton et al. 2007 IJSN"],
    ),

    # ── Drug-Supplement Interactions ────────────────────────────────────────

    Interaction(
        compound_a="statins", compound_b="coq10",
        severity="caution",
        mechanism="HMG-CoA reductase inhibition reduces mevalonate pathway output, including endogenous CoQ10 synthesis. Chronic statin therapy can reduce plasma CoQ10 by 30–50%.",
        evidence_tier="🟡",
        recommendation="Consider CoQ10 100–200mg/d (ubiquinol form preferred) if on statins, especially with myalgia complaints. Take with fatty meal.",
        sources=["Qu et al. 2018 Med Sci Monit", "Banach et al. 2015 Mayo Clin Proc"],
    ),
    Interaction(
        compound_a="metformin", compound_b="vitamin b12",
        severity="caution",
        mechanism="Metformin inhibits calcium-dependent B12 absorption in terminal ileum. Chronic use (>4 years, >1500mg/d) causes B12 deficiency in 10–30% of users.",
        evidence_tier="🟢",
        recommendation="Check serum B12 + methylmalonic acid annually. Supplement methylcobalamin 1000mcg/d if MMA elevated or B12 <400 pg/mL.",
        sources=["de Jager et al. 2010 BMJ", "Reinstatler et al. 2012 Diabetes Care"],
    ),
    Interaction(
        compound_a="ssri", compound_b="l-tryptophan",
        severity="avoid",
        mechanism="SSRIs increase synaptic serotonin; L-tryptophan is precursor to serotonin synthesis. Combination risks serotonin syndrome (tachycardia, hyperthermia, rigidity).",
        evidence_tier="🟡",
        recommendation="AVOID. Do not combine without psychiatric supervision. Same risk applies to 5-HTP, SAM-e.",
        sources=["Boyer & Shannon 2005 NEJM"],
    ),
    Interaction(
        compound_a="levothyroxine", compound_b="iron",
        severity="caution",
        mechanism="Iron forms insoluble complexes with levothyroxine in the GI tract, reducing thyroid hormone absorption by 30–50%.",
        evidence_tier="🟢",
        recommendation="Separate by minimum 4 hours. Take levothyroxine empty stomach in AM; iron with vitamin C later in day.",
        sources=["Campbell et al. 1992 Ann Intern Med", "John-Kalarickal et al. 2007 Thyroid"],
    ),
    Interaction(
        compound_a="proton pump inhibitors", compound_b="magnesium",
        severity="caution",
        mechanism="Chronic PPI use (>1 year) reduces intestinal absorption of magnesium via TRPM6/7 channel dysregulation, causing hypomagnesemia.",
        evidence_tier="🟢",
        recommendation="Check serum Mg every 6 months if on chronic PPI. Supplement magnesium glycinate 200–400mg/d; consider alternative acid suppression.",
        sources=["FDA Drug Safety Communication 2011", "Cundy & Dissanayake 2008 Clin Endocrinol"],
    ),
    Interaction(
        compound_a="beta-blockers", compound_b="caffeine",
        severity="monitor",
        mechanism="Beta-blockers antagonize beta-adrenergic response; caffeine acts via adenosine receptor blockade + catecholamine release. Net effect varies — reduced ergogenic benefit but also blunted side effects.",
        evidence_tier="🟡",
        recommendation="Expect reduced performance benefit from caffeine. Standard doses (3mg/kg) likely safe; avoid >6mg/kg with beta-blockers due to unpredictable BP response.",
        sources=["Smith et al. 2018 Br J Clin Pharmacol"],
    ),
    Interaction(
        compound_a="hormonal birth control", compound_b="vitamin b6",
        severity="monitor",
        mechanism="Estrogen in oral contraceptives depletes pyridoxal-5-phosphate (active B6) via increased tryptophan metabolism and altered B6 kinetics.",
        evidence_tier="🟡",
        recommendation="Consider B6 25–50mg/d (or B-complex) in athletes on hormonal contraception, especially if experiencing mood changes or PMS-like symptoms.",
        sources=["Wilson et al. 2011 Am J Clin Nutr", "Villegas-Salas et al. 1997 Contraception"],
    ),
    Interaction(
        compound_a="statins", compound_b="niacin",
        severity="caution",
        mechanism="Both affect lipid profile and liver function. Co-administration increases risk of myopathy, rhabdomyolysis, and hepatotoxicity, especially at high doses.",
        evidence_tier="🟢",
        recommendation="AIM-HIGH trial showed no added cardiovascular benefit from combination. Not recommended for routine use; monitor CK/AST/ALT if combined by physician.",
        sources=["AIM-HIGH Investigators 2011 NEJM", "HPS2-THRIVE Collaborative Group 2014 NEJM"],
    ),

    # ── Food-Drug and Food-Nutrient Interactions ────────────────────────────

    Interaction(
        compound_a="grapefruit", compound_b="statins",
        severity="caution",
        mechanism="Grapefruit furanocoumarins inhibit intestinal CYP3A4, increasing plasma statin levels 2-15x depending on statin. Risk of myopathy, rhabdomyolysis.",
        evidence_tier="🟢",
        recommendation="Avoid grapefruit juice with simvastatin, atorvastatin, lovastatin. Pravastatin, rosuvastatin, and fluvastatin are safer choices.",
        sources=["Bailey et al. 2013 CMAJ — Grapefruit-medication interactions"],
    ),
    Interaction(
        compound_a="grapefruit", compound_b="calcium channel blockers",
        severity="caution",
        mechanism="CYP3A4 inhibition increases bioavailability of felodipine, nifedipine, amlodipine. Risk of hypotension, peripheral edema.",
        evidence_tier="🟢",
        recommendation="Avoid grapefruit within 4 hours of dihydropyridine CCBs. Verify with pharmacist for specific medication.",
        sources=["Bailey et al. 1991 Lancet — Original grapefruit-felodipine interaction"],
    ),
    Interaction(
        compound_a="calcium", compound_b="tetracycline",
        severity="caution",
        mechanism="Calcium chelates with tetracycline antibiotics in GI tract, forming insoluble complexes that reduce antibiotic absorption by 50-80%.",
        evidence_tier="🟢",
        recommendation="Separate calcium supplements and dairy by 2-3 hours from tetracycline, doxycycline, or quinolone antibiotics.",
        sources=["Neuvonen 1976 Drugs — Divalent cation-tetracycline chelation"],
    ),
    Interaction(
        compound_a="cruciferous vegetables", compound_b="warfarin",
        severity="monitor",
        mechanism="Kale, spinach, broccoli, Brussels sprouts contain vitamin K which antagonizes warfarin. Inconsistent intake causes INR fluctuation.",
        evidence_tier="🟢",
        recommendation="Consistency over avoidance — maintain stable daily vitamin K intake. Inform prescriber before major dietary changes.",
        sources=["Schurgers et al. 2004 Thromb Haemost"],
    ),
    Interaction(
        compound_a="caffeine", compound_b="theophylline",
        severity="caution",
        mechanism="Caffeine is structurally similar to theophylline; both metabolized by CYP1A2. Additive effects on heart rate, BP, tremor, insomnia.",
        evidence_tier="🟢",
        recommendation="Reduce caffeine to <100mg/d in patients on theophylline for asthma/COPD. Monitor for toxicity signs.",
        sources=["Carrillo & Benitez 2000 Clin Pharmacokinet"],
    ),
    Interaction(
        compound_a="high-protein meal", compound_b="levodopa",
        severity="caution",
        mechanism="Large neutral amino acids compete with levodopa for the same BBB transporter. High-protein meals can reduce levodopa brain uptake by 30-50%.",
        evidence_tier="🟢",
        recommendation="Take levodopa 30 min before meals or 60 min after. Consider protein redistribution diet (most protein at dinner) for Parkinson's patients.",
        sources=["Nutt et al. 1984 NEJM — Protein-levodopa interaction"],
    ),

    # ── Tier 18: Coverage gap fills ────────────────────────────────────────

    Interaction(
        compound_a="curcumin", compound_b="anticoagulants",
        severity="caution",
        mechanism="Curcumin inhibits platelet aggregation and has mild anticoagulant properties. Additive bleeding risk with warfarin, aspirin, DOACs.",
        evidence_tier="🟡",
        recommendation="Monitor INR if on warfarin. Stop curcumin 2 weeks before surgery. At standard doses (500mg), risk is low.",
        sources=["Sahebkar 2013 Pharmacol Res"],
    ),
    Interaction(
        compound_a="quercetin", compound_b="cyclosporine",
        severity="caution",
        mechanism="Quercetin inhibits P-glycoprotein and CYP3A4, potentially increasing cyclosporine plasma levels.",
        evidence_tier="🟡",
        recommendation="Avoid combining without physician monitoring of cyclosporine levels.",
        sources=["Choi et al. 2011 Eur J Clin Pharmacol"],
    ),
    Interaction(
        compound_a="quercetin", compound_b="caffeine",
        severity="synergistic",
        mechanism="Both are adenosine receptor antagonists; quercetin enhances and prolongs caffeine's ergogenic effect via complementary receptor blockade.",
        evidence_tier="🟡",
        recommendation="Combine for enhanced endurance performance: 1000mg quercetin + 3mg/kg caffeine, taken 60 min pre-exercise.",
        sources=["Nieman et al. 2010 Med Sci Sports Exerc"],
    ),
    Interaction(
        compound_a="berberine", compound_b="metformin",
        severity="caution",
        mechanism="Both activate AMPK and lower blood glucose via overlapping mechanisms. Additive hypoglycemia risk.",
        evidence_tier="🟡",
        recommendation="Do not combine without physician supervision. If combined, monitor blood glucose closely and start with lower berberine dose.",
        sources=["Yin et al. 2008 Metabolism"],
    ),
    Interaction(
        compound_a="berberine", compound_b="statins",
        severity="caution",
        mechanism="Berberine inhibits CYP3A4 and CYP2D6. May increase plasma levels of simvastatin, atorvastatin, increasing myopathy risk.",
        evidence_tier="🟡",
        recommendation="Monitor for muscle pain/weakness. Consider pravastatin or rosuvastatin (less CYP3A4 dependent).",
        sources=["Guo et al. 2012 Planta Med"],
    ),
    Interaction(
        compound_a="nac", compound_b="nitroglycerin",
        severity="caution",
        mechanism="NAC potentiates nitroglycerin-induced vasodilation via enhanced nitric oxide production. Risk of severe hypotension.",
        evidence_tier="🟢",
        recommendation="Do not combine without cardiovascular supervision. Can cause dangerous blood pressure drops.",
        sources=["Horowitz et al. 1988 Circulation"],
    ),
    Interaction(
        compound_a="potassium", compound_b="ace inhibitors",
        severity="caution",
        mechanism="ACE inhibitors are potassium-sparing. Additional potassium supplementation increases hyperkalemia risk, especially with renal impairment.",
        evidence_tier="🟢",
        recommendation="Monitor serum potassium if supplementing while on ACE inhibitors or ARBs. Avoid potassium supplements >99mg/dose without physician guidance.",
        sources=["Palmer 2004 NEJM"],
    ),
    Interaction(
        compound_a="choline", compound_b="acetylcholinesterase inhibitors",
        severity="monitor",
        mechanism="Alpha-GPC increases acetylcholine; AChE inhibitors (donepezil, rivastigmine) prevent its breakdown. Additive cholinergic effect.",
        evidence_tier="🟠",
        recommendation="Monitor for excessive cholinergic symptoms (GI distress, sweating, bradycardia). Reduce alpha-GPC dose if combining.",
        sources=["Mechanistic; no direct clinical trial on combination"],
    ),
    Interaction(
        compound_a="rhodiola", compound_b="ssri",
        severity="monitor",
        mechanism="Rhodiola has mild MAO-inhibiting activity (salidroside). Theoretical serotonergic interaction with SSRIs, though no clinical cases reported.",
        evidence_tier="🟠",
        recommendation="Likely safe at standard doses (200-400mg/d) but monitor for serotonergic symptoms. Inform prescriber.",
        sources=["Van Diermen et al. 2009 Planta Med"],
    ),
    Interaction(
        compound_a="phosphatidylserine", compound_b="anticoagulants",
        severity="monitor",
        mechanism="Phospholipids can affect platelet membrane composition. Theoretical additive effect on bleeding time at high doses (>600mg/d).",
        evidence_tier="🟠",
        recommendation="Standard doses (100-300mg/d) likely safe. Monitor at cortisol-protocol doses (600-800mg/d) if on anticoagulants.",
        sources=["Theoretical; limited clinical data"],
    ),

    # ── Tier 19: Contributed from Calsanova app/supplements/extra_interactions.py 2026-04-26 ──
    # 7 pairs that the Calsanova /stacking UI surfaced via a backend gap-fill
    # module. Promoted upstream so the gap-fill module can be deleted and
    # interaction lookups have a single canonical source. Evidence tier 🟡
    # (Moderate) on all rows — established mechanism, no landmark RCT cited
    # inline; clinical review may upgrade individual rows later.
    Interaction(
        compound_a="iron", compound_b="vitamin d",
        severity="caution",
        mechanism=(
            "Vitamin D enhances calcium absorption; calcium then competes with "
            "iron for the same divalent metal transporter. Effect is indirect."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Take vitamin D and iron 2+ hours apart when both are supplemented "
            "at therapeutic doses."
        ),
    ),
    Interaction(
        compound_a="zinc", compound_b="calcium",
        severity="caution",
        mechanism=(
            "High-dose calcium reduces zinc absorption by competing for "
            "divalent metal transporters in the small intestine."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Take zinc and calcium at separate meals; especially relevant when "
            "calcium ≥ 600 mg per dose."
        ),
    ),
    Interaction(
        compound_a="vitamin d", compound_b="calcium",
        severity="synergistic",
        mechanism=(
            "Vitamin D upregulates intestinal calcium binding protein "
            "(calbindin); supplementation increases calcium absorption by "
            "up to 40%."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Pairing is appropriate. Maintain adequate vitamin D status when "
            "supplementing calcium."
        ),
    ),
    Interaction(
        compound_a="citrulline", compound_b="beta-alanine",
        severity="synergistic",
        mechanism=(
            "Citrulline increases nitric oxide / blood flow; beta-alanine "
            "raises intramuscular carnosine for acid buffering. Mechanisms "
            "are independent and complementary."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Combination is well-tolerated and frequently stacked pre-workout."
        ),
    ),
    Interaction(
        compound_a="omega-3", compound_b="vitamin d",
        severity="synergistic",
        mechanism=(
            "Vitamin D is fat-soluble. Co-ingestion with the fat from omega-3 "
            "fish oil improves vitamin D bioavailability."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Take vitamin D with the meal that contains your omega-3 dose."
        ),
    ),
    Interaction(
        compound_a="whey protein", compound_b="creatine",
        severity="synergistic",
        mechanism=(
            "Insulin response from whey protein may enhance creatine uptake "
            "into muscle."
        ),
        evidence_tier="🟡",
        recommendation="Frequent post-workout pairing; well-tolerated.",
    ),
    Interaction(
        compound_a="whey protein", compound_b="bcaas",
        severity="caution",
        mechanism=(
            "Whey protein already contains the three branched-chain amino "
            "acids in their natural ratio. Additional BCAA supplementation "
            "alongside whey is largely redundant."
        ),
        evidence_tier="🟡",
        recommendation=(
            "Drop standalone BCAAs if already taking whey post-workout; may "
            "waste budget without performance gain."
        ),
    ),
]

# Build lookup index for fast searching
_INDEX: dict[str, list[Interaction]] = {}
for _i in INTERACTION_DB:
    for _key in [_i.compound_a, _i.compound_b]:
        _INDEX.setdefault(_key.lower(), []).append(_i)


# ── Public API ─────────────────────────────────────────────────────────────────

def lookup_interactions(
    compounds: list[str],
    min_severity: Severity = "monitor",
) -> list[Interaction]:
    """
    Find all known interactions between a list of compounds.
    Returns interactions sorted by severity (most dangerous first).
    """
    compounds_lower = [c.lower().strip() for c in compounds]
    found: set[int] = set()
    results: list[Interaction] = []

    for comp in compounds_lower:
        for interaction in _INDEX.get(comp, []):
            obj_id = id(interaction)
            if obj_id in found:
                continue

            # Check if both parties are in the requested compound list
            a = interaction.compound_a.lower()
            b = interaction.compound_b.lower()
            if a in compounds_lower and b in compounds_lower:
                # Both specified — always include regardless of min_severity
                results.append(interaction)
                found.add(obj_id)
            elif a in compounds_lower or b in compounds_lower:
                # One specified — only include if at or above severity threshold
                if SEVERITY_ORDER.get(interaction.severity, 4) <= SEVERITY_ORDER.get(min_severity, 2):
                    results.append(interaction)
                    found.add(obj_id)

    return sorted(results, key=lambda x: SEVERITY_ORDER.get(x.severity, 4))


def lookup_single(compound: str) -> list[Interaction]:
    """Get all known interactions for a single compound."""
    comp = compound.lower().strip()
    return sorted(
        _INDEX.get(comp, []),
        key=lambda x: SEVERITY_ORDER.get(x.severity, 4),
    )


def format_interaction_report(
    compounds: list[str],
    interactions: list[Interaction],
) -> str:
    """Format a complete interaction report for display."""
    lines = [
        "Supplement Interaction Report",
        f"Compounds checked: {', '.join(c.title() for c in compounds)}",
        f"Total interactions found: {len(interactions)}",
        "=" * 60,
    ]

    if not interactions:
        lines.append("\n✅ No significant interactions found in database.")
        lines.append("Note: Database covers common athletic supplements.")
        lines.append("For novel compounds, use Claude analysis (/check <compound>).")
        return "\n".join(lines)

    by_severity: dict[str, list[Interaction]] = {}
    for i in interactions:
        by_severity.setdefault(i.severity, []).append(i)

    for sev in ["avoid", "caution", "monitor", "synergistic", "safe"]:
        group = by_severity.get(sev, [])
        if not group:
            continue
        emoji = SEVERITY_EMOJI[sev]
        lines.append(f"\n{emoji} {sev.upper()} ({len(group)})")
        lines.append("-" * 40)
        for ix in group:
            lines.append(ix.display())

    return "\n".join(lines)


# ── Claude Fallback for Novel Compounds ──────────────────────────────────────

NOVEL_COMPOUND_SYSTEM = """\
You are a pharmacology and sports nutrition specialist. When given compounds \
that are not in the local interaction database, analyze potential interactions \
using your knowledge of:
- Pharmacokinetics (absorption, metabolism, CYP enzyme interactions)
- Pharmacodynamics (receptor competition, synergistic/antagonistic effects)
- Clinical evidence and case reports
- Theoretical mechanistic concerns

For each interaction found, provide:
1. Severity: synergistic / safe / monitor / caution / avoid
2. Evidence tier: 🟢 Strong | 🟡 Moderate | 🟠 Weak | 🔵 Emerging
3. Mechanism of interaction
4. Practical recommendation

Be specific and evidence-grounded. If evidence is limited, say so explicitly. \
Never fabricate references — cite only well-known landmark studies or state \
"mechanistic basis only" when appropriate.\
"""


async def analyze_novel_interactions(
    client: anthropic.AsyncAnthropic,
    compounds: list[str],
    on_text=None,
) -> str:
    """
    Use Claude to analyze interactions for compounds not in the local DB.

    Falls back to Claude Opus 4.6 with adaptive thinking when the local
    interaction database has no data for one or more compounds.

    Args:
        client: AsyncAnthropic client.
        compounds: List of compound names to check.
        on_text: Optional streaming callback.

    Returns:
        Analysis text from Claude.
    """
    prompt = (
        f"Analyze potential interactions between these compounds:\n"
        f"{', '.join(c.title() for c in compounds)}\n\n"
        f"For each pair with a meaningful interaction, provide severity, "
        f"evidence tier, mechanism, and recommendation. If a compound is "
        f"obscure, note limited evidence availability."
    )

    messages = [{"role": "user", "content": prompt}]

    if on_text:
        accumulated = ""
        async with client.messages.stream(
            model="claude-opus-4-6",
            max_tokens=4096,
            thinking={"type": "adaptive"},
            system=NOVEL_COMPOUND_SYSTEM,
            messages=messages,
        ) as stream:
            async for text in stream.text_stream:
                on_text(text)
                accumulated += text
        return accumulated
    else:
        response = await client.messages.create(
            model="claude-opus-4-6",
            max_tokens=4096,
            thinking={"type": "adaptive"},
            system=NOVEL_COMPOUND_SYSTEM,
            messages=messages,
        )
        return next(b.text for b in response.content if b.type == "text")


def has_novel_compounds(compounds: list[str]) -> list[str]:
    """
    Check which compounds are NOT in the local interaction database.

    Returns list of compound names not found in the index.
    """
    novel = []
    for comp in compounds:
        if comp.lower().strip() not in _INDEX:
            novel.append(comp)
    return novel
